Information:
Error:
ID
34306
Description
Vitamin D Supplementation for Treatment of Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01230307
Link
https://clinicaltrials.gov/show/NCT01230307
Keywords
Versions (1)
- 1/16/19 1/16/19 -
Copyright Holder
GSK group of companies
Uploaded on
January 16, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Heart Failure NCT01230307
Eligibility Heart Failure NCT01230307
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT01230307
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
hf patients with lv systolic dysfunction of ischemic or non-ischemic origin and an lvef <40% using nuclear ventriculography or echocardiography within the last 6 months.
boolean
ID.2
Item
attempts should have been made at optimizing medical therapy and the participant should be stable on these medications for at least 3 months.
boolean
ID.3
Item
patients with a 25(oh)d level between 10-25 ng/ml
boolean
ID.4
Item
inability to give informed consent
boolean
ID.5
Item
patients with sarcoidosis or other granulomatous disease that can alter vitamin d metabolism
boolean
ID.6
Item
patients with primary valvular hf, hypertrophic cardiomyopathy, and drug-induced hf
boolean
ID.7
Item
renal dysfunction defined as serum creatinine > 2.5 mg/dl
boolean
ID.8
Item
pregnant women
boolean
ID.9
Item
patients <18 years of age
boolean
ID.10
Item
patients on vitamin d supplementation
boolean